Rankings
▼
Calendar
APLS Q1 2016 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
APLS
Apellis Pharmaceuticals, Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.37
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$363,403
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$35M
Cash & Equivalents
-$36M
← FY 2016
All Quarters
Q2 2016 →
